Back to News
Market Impact: 0.35
Corcept Therapeutics (CORT) Q3 Earnings and Revenues Surpass Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechCompany FundamentalsAnalyst Estimates
Corcept Therapeutics reported quarterly earnings of $1.01 per share, 48% above the Zacks Consensus Estimate of $0.68. Earnings increased from $0.16 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
CORT0.70
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AMD rides data center riches to ‘largest and most profitable’ quarter in history
- ‘Lawyer up’: Democrats take the House, and warn Trump’s family businesses are first in line for subpoenas